Parallax Volatility Advisers, L.P. Novo Cure LTD Transaction History

Parallax Volatility Advisers, L.P.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $103,272 - $143,766	8,315 Added 445.13%	10,183 $159,000
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $20,790 - $29,477	1,868 New	1,868 $27,000
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $395,567 - $810,083	9,818 New	9,818 $407,000
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $1.14 Million - $1.75 Million	-9,187 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $532,307 - $815,639	4,289 Added 87.57%	9,187 $1.21 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $549,359 - $852,937	4,898 New	4,898 $848,000
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $1.45 Million - $2.26 Million	-12,951 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$58.05 - $111.31 $1.04 Million - $1.99 Million	-17,853 Reduced 57.96%	12,951 $1.44 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $1.37 Million - $1.78 Million	-23,971 Reduced 43.76%	30,804 $1.83 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $3.12 Million - $5.24 Million	54,775 New	54,775 $3.69 Million
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $98,724 - $173,354	-3,089 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$28.72 - $52.63 $88,716 - $162,574	3,089 New	3,089 $103,000
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $608,640 - $996,648	-19,020 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $203,303 - $327,744	10,242 Added 116.68%	19,020 $595,000
Q4 2017 Feb 14, 2018	BUY	$16.3 - $21.9 $143,081 - $192,238	8,778	8,778 $177,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.